Literature DB >> 4063166

Muir-Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome.

H T Lynch, R M Fusaro, L Roberts, G J Voorhees, J F Lynch.   

Abstract

Distinguishing cutaneous signs which are associated with hereditary cancer-prone syndromes are known as cancer-associated genodermatoses. Muir-Torre syndrome (M-T) is characterized by the occurrence of sebaceous hyperplasia, adenoma and carcinoma, basal cell carcinoma with sebaceous differentiation, and/or keratoacanthoma in association with visceral cancer (often multiple), and improved survival. Family studies of M-T have been either wholly lacking or too incomplete to elucidate hereditary aetiology. We describe the cutaneous phenotype of M-T in an extended kindred with a possible variant of the Cancer Family Syndrome. We emphasize the need for more thorough documentation of family histories and cancer association in this cancer-associated genodermatosis in order to clarify hereditary syndrome identification, and to improve cancer control through employment of cutaneous signs as a beacon for highly targeted forms of visceral cancer.

Entities:  

Mesh:

Year:  1985        PMID: 4063166     DOI: 10.1111/j.1365-2133.1985.tb02081.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

1.  The genetic basis of Muir-Torre syndrome includes the hMLH1 locus.

Authors:  B Bapat; L Xia; L Madlensky; A Mitri; P Tonin; S A Narod; S Gallinger
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

Review 2.  Lynch syndrome: clinical, pathological, and genetic insights.

Authors:  Ralph Schneider; Claudia Schneider; Matthias Kloor; Alois Fürst; Gabriela Möslein
Journal:  Langenbecks Arch Surg       Date:  2012-02-24       Impact factor: 3.445

Review 3.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

Review 4.  Genetics of skin appendage neoplasms and related syndromes.

Authors:  D A Lee; M E Grossman; P Schneiderman; J T Celebi
Journal:  J Med Genet       Date:  2005-11       Impact factor: 6.318

5.  Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome.

Authors:  N J Froggatt; C Brassett; D J Koch; D G Evans; S V Hodgson; B A Ponder; E R Maher
Journal:  J Med Genet       Date:  1996-09       Impact factor: 6.318

6.  Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.

Authors:  Mala Pande; Chongjuan Wei; Jinyun Chen; Christopher I Amos; Patrick M Lynch; Karen H Lu; Laura A Lucio; Stephanie G Boyd-Rogers; Sarah A Bannon; Maureen E Mork; Marsha L Frazier
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

7.  Inherited colorectal cancer syndromes.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2005-08

8.  Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms.

Authors:  Maegan E Roberts; Douglas L Riegert-Johnson; Brittany C Thomas; Colleen S Thomas; Michael G Heckman; Murli Krishna; David J DiCaudo; Alina G Bridges; Katherine S Hunt; Kandelaria M Rumilla; Mark A Cappel
Journal:  J Genet Couns       Date:  2012-12-06       Impact factor: 2.537

9.  Abnormal vascular network complexity: a new phenotypic marker in hereditary non-polyposis colorectal cancer syndrome.

Authors:  C De Felice; G Latini; G Bianciardi; S Parrini; G M Fadda; M Marini; R N Laurini; R J Kopotic
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

10.  Muir-Torre syndrome: a variant of the cancer family syndrome.

Authors:  N R Hall; M A Williams; V A Murday; J A Newton; D T Bishop
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.